Trial Profile
Safety and efficacy of thrombomodulin treatment for disseminated intravascular coagulation in patients with acute promyelocytic leukemia.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Jun 2014
Price :
$35
*
At a glance
- Drugs Thrombomodulin alfa (Primary)
- Indications Disseminated intravascular coagulation
- Focus Adverse reactions; Therapeutic Use
- 09 Jun 2014 New trial record